← Open Payments lookup

LINDA MUEHL: Open Payments

NPI 1326018664 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$958 in 10 payments from 9 companies in 2025. Trend: 2023 $852 · 2024 $831 · 2025 $958

Food & beverage: $958
CompanyPaymentsAmount
Amgen Inc.2$205
Novo Nordisk Inc1$125
Dexcom, Inc.1$115
Teva Pharmaceuticals USA, Inc.1$103
Phathom Pharmaceuticals, Inc.1$97
Neurocrine BioSciences, Inc.1$83
Sage Therapeutics, LLC1$80
COLOPLAST CORP1$77
Boehringer Ingelheim Pharmaceuticals, Inc.1$73

Products named: Wegovy, DEXCOM G7 GSS (161), REPATHA, AUSTEDO XR, KRYSTEXXA, VOQUEZNA, INGREZZA, Titan.

Industry payments across MD — which companies pay providers there.